Inclusion Criteria:  Behçet's disease (BD) patients fulfilling the International Criteria for Behçet's disease (ICBD) published in 2013 with recent recurrence of pan- or posterior uveitis The patient should be on ≥10mg/d oral prednisone or equivalent  Exclusion Criteria:  Previous treatment with TNFα inhibitors within 3 months Pregnancy, breast feeding women Malignancy Heart failure Demyelinating diseases Renal impairment (creatinine > 1.5 mg/dl) Depression or other psychic disorders History of acute or chronic inflammatory joint or autoimmune disease Patients with severe extra-ocular involvement other than oral/genital ulcer and skin involvement Organ or bone marrow transplant recipient, cardiac failure > NYHA III Acute liver disease with ALT or SGPT 2x above normal White blood cell count < 3500/mm^3 Platelet count < 100000/mm^3 Hgb < 8.5g/dl T-SPOT TB: ≥200 SFCs per 10^6 PBMC Active peptic ulcer, systemic or local infection, moderate to severe osteoporosis or other contraindications of intermediate dose corticosteroids Other severe ocular diseases or intraocular surgery within 3 months Media opacity precluding a clear view of the fundus Positive screen test for HBV, HCV, HIV infection or syphilis Body weight <45 kg Alcohol abuse or drug abuse Mental impairment Uncooperative attitude